Active Choice and Financial Incentives to Increase Rates of Screening Colonoscopy-A Randomized Controlled Trial.
Mehta, Shivan J; Feingold, Jordyn; Vandertuyn, Matthew; Niewood, Tess; Cox, Catherine; Doubeni, Chyke A; Volpp, Kevin G; Asch, David A.
; 153(5): 1227-1229.e2, 2017 11.
Artigo em Inglês | MEDLINE | ID: mdl-28734830
Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs.
Costs and benefits of an organized fecal immunochemical test-based colorectal cancer screening program in the United States.
Cost-effectiveness of a patient navigation intervention to increase colonoscopy screening among low-income adults in New Hampshire.
Cost Effectiveness of Age-Specific Screening Intervals for People With Family Histories of Colorectal Cancer.
Direct access colonoscopy service for bowel cancer screening produces a positive financial benefit for patients and local health districts.
Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years.
Developmental milestones across the programmatic life cycle: implementing the CDC's Colorectal Cancer Screening Demonstration Program.
Economic assessment of patient navigation to colonoscopy-based colorectal cancer screening in the real-world setting at the University of Chicago Medical Center.
Recruiting patients into the CDC's Colorectal Cancer Screening Demonstration Program: strategies and challenges across 5 sites.
Personalized medicine for prevention: can risk stratified screening decrease colorectal cancer mortality at an acceptable cost?